학술논문
주요우울장애 환자에서 Brain-Derived Neurotrophic Factor 유전자 다형성과 선택적 세로토닌 흡수 차단제의 치료반응도간의 연관성 연구
이용수 61
- 영문명
- Association Study Between Brain-Derived Neurotrophic Factor Genetic Polymorphism and Treatment Responses of Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
- 발행기관
- 대한노인정신의학회
- 저자명
- 이영민(Young Min Lee)
- 간행물 정보
- 『노인정신의학』노인정신의학 제12권 제1호, 34~39쪽, 전체 6쪽
- 주제분류
- 의약학 > 정신과학
- 파일형태
- 발행일자
- 2008.06.30
4,000원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
Objectives : Recent studies suggest that brain-derived neurotrophic factor (BDNF) may play a critical role in both mechanism of antidepressant action and the pathophysiology of major depressive disorder (MDD). The aim of this study is to evaluate whether the BDNF-gene Val66Met polymorphism is associated with susceptibility of MDD, and antidepressant response in a Korean population. Methods : To explain genetic susceptibility of MDD, we genotyped the BDNF-gene Val66Met polymorphism in 137 patients with MDD and 91 age- and sex-similar control subjects. we also examined the association of the BDNF-gene Val66Met polymorphism and therapeutic response in 137 MDD patients who received a 6-week Selective Serotonin Reuptake Inhibitor (SSRI) treatment. Results : There were no significant differences in the genotype or allele frequency of the BDNF polymorphism, between the MDD and control subjects. Furthermore, no significant differences were noted in the three-genotype groups (Val/Val, Val/Met, Met/Met) between responders and non-responders. However, heterozygous patients (Val/Met) in comparison to homozygous analogs (Val/Val or Met/Met) in BDNF polymorphism tended to have more improved 6-week antidepressant response (p=0.053). In addition, higher total HAM-D-score percentage change after 6 weeks of antidepressant medication was demonstrated for the heterozygote patients in comparison to homozygous analogs (p=0.006). Conclusion : This finding suggests the BDNF polymorphism is associated with improved therapeutic SSRI response for patients bearing the BDNF Val/Met heterozygote in comparison to the homozygous analogs.
목차
서 론
방 법
결 과
고 찰
키워드
해당간행물 수록 논문
참고문헌
관련논문
의약학 > 정신과학분야 BEST
- 한국판 세계보건기구 삶의 질 간편형 척도 (WHOQOL-BREF)의 개발
- 학교생활 부적응을 겪는 ADHD 아동의 아동중심놀이치료 사례 연구 - 치료단계별 놀이주제 및 놀이행동 분석을 중심으로 -
- 한국형 노인우울검사(Korean Form of Geriatric Depression Scale;KGDS) 표준화 연구
의약학 > 정신과학분야 NEW
- Development and Validation of the Mental Health Scale for Maltreated Children
- Polysomnography and Neuropsychological Analysis of Patients With Post-Traumatic Stress Disorder Two Years After the COVID-19 Pandemic in Wuhan
- The Relationship Between Interoceptive Awareness, Emotion Regulation and Clinical Symptoms Severity of Depression, Anxiety and Somatization
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!